Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersGynecologic Oncology Physician in Mineola, NY
NPI: 1376542829Primary Employer
NYU Faculty Group Practice
nyulangone.org
HQ Phone
Get M.D. Eva's Phone Numberphone_androidMobile
Get M.D. Eva's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNY State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 80 | 131 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 50 | 85 |
| 3 | 36415Insertion of needle into vein for collection of blood sample | 36 | 48 |
| 4 | 99205New patient office or other outpatient visit, typically 60 minutes | 17 | 17 |
| 5 | 99215Established patient office or other outpatient, visit typically 40 minutes | 15 | 19 |
Regarding "Incidence of Occult Uterine Malignancy Following Vaginal Hysterectomy with Morcellation".
Authors: Elizabeth Pritts, William Parker, Jonathan Berek, Daniel Clarke-Pearson
Journal: J Minim Invasive Gynecol
Publication Date: 2017-02-24
Authors: Fernanda Musa, Scott Gorenstein, Courtney Griffiths, Edward Jimenez
Journal: Gynecol Oncol Rep
Publication Date: 2018-04-13
Authors: Edward Jimenez, Deanna Gerber, Kent Chan
Journal: Int J Genomics
Publication Date: 2025-03-01
Lead Sponsor: pharmaand GmbH
Collaborators: Foundation Medicine
Intervention / Treatment: DRUG: Chemotherapy, DRUG: Rucaparib
Lead Sponsor: ImmunoVaccine Technologies, Inc. (IMV Inc.)
Collaborators: Merck Sharp & Dohme LLC
Intervention / Treatment: DRUG: Pembrolizumab, DRUG: Cyclophosphamide, OTHER: DPX-Survivac
Lead Sponsor: Gynecologic Oncology Group
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: Carboplatin, OTHER: Questionnaire Administration, OTHER: Laboratory Biomarker Analysis, OTHER: Quality-of-Life Assessment, DRUG: Paclitaxel, OTHER: Placebo Administration, DRUG: Metformin Hydrochloride